National Pharmaceutical Pricing Authority brings 42 non-scheduled cancer drugs under price control, caps trade margin at 30%
• 6 years agoCurrently, 57 anti-cancer drugs are under price control as scheduled formulations
World Cancer Day: Compulsory licensing of key drugs only way for India to fight this grave threat
Fp Archives • 9 years agoAbout four years ago, cancer usually meant a slow death, coupled with a vain fight, for the common man. It was largely because of the exorbitant costs of medicines.
SC terms drugs policy 'unreasonable', asks Centre to re-look
Fp Archives • 10 years agoThe court was hearing a PIL filed by NGO All India Drug Action Network alleging that the MBP was never used for any price regulatory purposes and this was making medicines costlier.
CCEA clears Glenmark, Aurobindo foreign funding proposals worth Rs 4,187 cr
Fp Archives • 10 years agoThe decision was taken by the Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi.
Govt forms committee for revising List of Essential Medicines
Fb_admin • 10 years agoThe report of the committee is yet to be submitted, State Minister of Chemicals and Fertilizers Hans Raj Gangaram Ahir informed Parliament.
De-controlling drug prices: SC refuses to interfere in Centre's decision
Fp Archives • 10 years agoThe Supreme Court today refused to interfere with the Centre's decision to de-control prices of 108 cardiac and diabetes drugs saying the issue can be raised before the competent authority through representation.
Prices of 440 essential drugs cut last month: Govt
Fp Archives • 11 years agoThere are 680 formulations under the National List of Essential Medicines (NLEM). Of these, the National Pharmaceutical Pricing Authority (NPPA) has fixed ceiling prices in respect of 440 medicines as on June 30